Dieter Weinand
Independent Chairman of the Supervisory BoardMr. Dieter Weinand is Chairman of the Board of Fore Biotherapeutics Inc. from February 2021. He serves as Independent Chairman of the Supervisory Board since June 11, 2026 at Evotec SE. He has M.S. in Pharmacology, Toxicology from Long Island University in 1987, B.A. in Biology from Concordia University in 1982. He was Chair of the Board at Anaveon AG from July 2024 to May 2026. He is Chairman of Meliora Therapeutics, Inc. since July 2024. He serves as Chairman of Clasp Therapeutics Inc. and Artisan Bio Inc. He is Chairman of AstriVax NV since June 12, 2025. He serves as Independent Chairman at Confo Therapeutics since August 2023. He serves as an Independent Director of Coya Therapeutics, Inc. since August 21, 2023. He has been Executive Chair of ZielBio, Inc. since December 2020. He served as Chairman of the Board at Umoja BioPharma, Inc. since November 17, 2022 until November 2024. He is Executive Chairman of the Board of Mnemo Therapeutics. He serves as Chairman at NovellusDx, Ltd. since February 2021. He serves as Lead Independent Director of Replimune Group, Inc. since April 1, 2024. He served as an Independent Chairman at Replimune Group, Inc. since April 2, 2020 until April 1, 2024 and serves as its Director since June 2018. He has general management and commercial leadership experience with executive management roles at Sanofi, Pfizer and BMS among others. He serves as an Independent Director of Reunion Neuroscience Inc. (formerly known as Field Trip Health Ltd.) (Formerly known as Field Trip Health Inc.) since April 2020. He is Chairman of the Board of Directors of ForeBio and Chairman of the Board of Mnemo. He is Director at Vesigen, Inc. since April 2021. He was an Executive Vice President of Primary Care at Sanofi since November 1, 2018 until 2020. He served as President of the Pharmaceutical Division at Bayer Corporation. He served as the Head of The Pharmaceuticals Division and Member of Management Board at Bayer Aktiengesellschaft from January 1, 2016 to October 31, 2018. He is also responsible for the region North America. He has been the Head of Pharmaceuticals Division for HealthPrize Technologies LLC since January 12, 2015. He was CEO and Chairman of the Board of Management of Bayer Pharma AG and Member of the Management Board at Bayer AG. He served as the Head of the Pharmaceuticals Division of Bayer HealthCare AG and Bayer Pharma AG since August 01, 2014. He has extensive experience in senior executive roles with a number of pharmaceutical companies, including Sanofi, Otzuka and Pfizer. He has a demonstrated ability to recognize opportunity, create a vision and strategy and mobilize organizations behind successful execution. He has experience in various commercial operative and strategic executive roles in the pharmaceutical industry. He is responsible for different markets such as Asia Pacific, Europe, Middle East, Africa, Latin America and the USA at companies including Pfizer and Bristol Myers Squibb as well as for the marketing of products in different therapeutic areas such as cardiology, oncology, dermatology, immunology, pulmonology and inflammation. He has launched and marketed some of the industry's most successful products, including Lipitor, Neurontin, Abilify and Cipro. He served as the President of Bayer HealthCare Pharmaceuticals Inc. since August 1, 2014. Prior to joining Bayer HealthCare, he served as the President of Global Commercialization & Portfolio Management at Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA. He had been a Director of HealthPrize Technologies LLC since January 12, 2015. He is a Board Member of the Pharmaceutical Research and Manufacturers of America (PhRMA) and a Board Member of the European Federation of Pharmaceutical Industries & Associations (EFPIA).
Positions
- Company NameEvotec SEStock CodeEVOPositionIndependent Chairman of the Supervisory BoardColleagues
- CWChristian WojczewskiCEO & Chairperson of the Management Board
- DWDieter WeinandIndependent Chairman of the Supervisory Board
- ADAurelie DalbiezChief People Officer & Member of Management Board
- CHClaire HinshelwoodCFO & Member of Management Board
- IMIngrid MllerCOO & Member of Management Board
- JHJoanna HolbrookChief Scientific Officer & Member of the Management Board
- RSRoland SackersIndependent Vice Chairperson of the Supervisory Board
- CUConstanze Ulmer-EilfortIndependent Member of Supervisory Board
- WPWesley Potter WheelerIndependent Member of the Supervisory Board
- DMDuncan McHaleIndependent Member of the Supervisory Board
- Company NameCoya Therapeutics, Inc.Stock CodeCOYAPositionIndependent DirectorColleagues
- ASArun SwaminathanCEO & Director
- FGFred GrossmanPresident & Chief Medical Officer
- DSDavid S. SnyderCFO & COO
- ATAaron ThomeHead of Neuroinflammation Platform
- MFMichelle FrazierSenior Vice President of Regulatory
- AVAnabella VillalobosIndependent Director
- DADov A. GoldsteinIndependent Director
- DWDieter WeinandIndependent Director
- ALAnn L. LeeIndependent Director
- Company NameReplimune Group, Inc.Stock CodeREPLPositionLead Independent Director
